1	Regulation	regulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	fas-ligand	fas-ligand	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	during	during	_	_	_	_	_	_	_
6	activation-induced	activation-induced	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	death	death	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphocytes	lymphocyte	_	_	_	_	_	_	_
12	via	via	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	kappaB	kappab	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	T	t	_	_	_	_	_	_	_
2	cell	cell	_	_	_	_	_	_	_
3	receptor	receptor	_	_	_	_	_	_	_
4	engagement	engagement	_	_	_	_	_	_	_
5	activates	activate	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	factors	factor	_	_	_	_	_	_	_
8	important	important	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	cytokine	cytokine	_	_	_	_	_	_	_
11	gene	gene	_	_	_	_	_	_	_
12	regulation	regulation	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Additionally	additionally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	signaling	signaling	_	_	_	_	_	_	_
5	pathway	pathway	_	_	_	_	_	_	_
6	also	also	_	_	_	_	_	_	_
7	leads	lead	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	activation-induced	activation-induced	_	_	_	_	_	_	_
10	apoptosis	apoptosis	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	lymphocytes	lymphocyte	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	dependent	dependent	_	_	_	_	_	_	_
17	on	on	_	_	_	_	_	_	_
18	FasL	FasL	_	_	_	_	_	_	_
19	transcription	transcription	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	kappaB	kappaB	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	involved	involve	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	regulation	regulation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	many	many	_	_	_	_	_	_	_
21	cytokine	cytokine	_	_	_	_	_	_	_
22	genes	gene	_	_	_	_	_	_	_
23	expressed	express	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	activated	activate	_	_	_	_	_	_	_
26	lymphocytes	lymphocyte	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	also	also	_	_	_	_	_	_	_
29	plays	play	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	role	role	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	T	t	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	activation-induced	activation-induced	_	_	_	_	_	_	_
36	FasL	FasL	_	_	_	_	_	_	_
37	expression	expression	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	hybridoma	hybridoma	_	_	_	_	_	_	_
10	leads	lead	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	decreased	decrease	_	_	_	_	_	_	_
13	FasL	fasl	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	apoptosis	apoptosis	_	_	_	_	_	_	_
17	upon	upon	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	receptor	receptor	_	_	_	_	_	_	_
21	stimulation	stimulation	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	identified	identify	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	site	site	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	FasL	FasL	_	_	_	_	_	_	_
9	promoter	promoter	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	contributes	contribute	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	such	such	_	_	_	_	_	_	_
14	regulation	regulation	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Co-expression	Co-expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	p65	p65	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	Rel	Rel	_	_	_	_	_	_	_
6	A	A	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	FasL	FasL	_	_	_	_	_	_	_
11	promoter	promoter	_	_	_	_	_	_	_
12	enhanced	enhance	_	_	_	_	_	_	_
13	its	its	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	co-expression	co-expression	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	IkappaB	IkappaB	_	_	_	_	_	_	_
20	dramatically	dramatically	_	_	_	_	_	_	_
21	inhibited	inhibit	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	inducible	inducible	_	_	_	_	_	_	_
24	promoter	promoter	_	_	_	_	_	_	_
25	activity	activity	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	transcription	transcription	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	AP-1	ap-1	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	required	require	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	activation-induced	activation-induced	_	_	_	_	_	_	_
13	FasL	FasL	_	_	_	_	_	_	_
14	promoter	promoter	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	define	define	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	role	role	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	mediating	mediate	_	_	_	_	_	_	_
10	FasL	fasl	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	during	during	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

